Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ghrelin versus placebo for cancer-related anorexia/cachexia
ISRCTN26185223Phase 2Completed
- Sponsor
- Kantonsspital St. Gallen
- Start
- Mar 2004
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised trial of human ghrelin in cancer anorexia-cachexia syndrome (CACS) and anorexia nervosa (AN), sponsored by Kantonsspital St. Gallen. Primary endpoints: Safety of parenteral ghrelin and Qualitative and quantitative toxicities. Started Mar 2004; status: completed.
02
Drugs
human ghrelin
03
Conditions
cancer anorexia-cachexia syndrome (CACS)anorexia nervosa (AN)
Beyond the preview
Go deeper on ISRCTN26185223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN26185223.